Sinus histiocytosis with massive lymphadenopathy and langerhans cell histiocytosis express the cellular adhesion molecule CD31

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 3, 2003, Pages 341-344

  Slone, Stephen P ^a   Fleming, Donald R ^a   Buchino, John J ^a,b  

^a University of Louisville School of Medicine   (United States)

^b KOSAIR CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CELL MARKER; FORMALDEHYDE; PROTEIN S100B;

ANTIBODY LABELING; ANTIGEN EXPRESSION; ARTICLE; CANCER CYTODIAGNOSIS; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; EPIDERMIS; GRANULAR CELL TUMOR; GRANULOMA; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL HISTIOCYTOSIS; LYMPHADENOPATHY; MELANOMA; PROTEIN EXPRESSION; SINUS HISTIOCYTOSIS; SKIN;

ANTIGENS, CD31; CELL MOVEMENT; FORMALDEHYDE; HISTIOCYTOSIS, LANGERHANS-CELL; HISTIOCYTOSIS, SINUS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC DISEASES; PARAFFIN EMBEDDING; S100 PROTEINS; TISSUE FIXATION;

EID: 0037344903     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological entity. Arch Pathol. 1969;87:63-70.
2. Rosai J, Dorfman RF. Sinus histocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder: analysis of 34 cases. Cancer. 1972;30:1174-1188.
3. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7:19-73.
4. Paulli M, Bergamaschi G, Tonon L, et al. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (RosaiDorfman disease). Br J Haematol. 1995;91:415-418.
5. Cline MJ. Histiocytes and histiocytosis [review]. Blood. 1994;84:2840-2853.
6. McClelland J, Pritchard J, Chu AC. Current controversies. Hematol Oncol Clin North Am. 1987;1:147-162.
7. Favara BE, Jaffe R. Pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1987;1:75-97.
8. Willman CL, Busque L, Griffith BB, et al. Langerhans-cell histiocytosis (histiocytosis x): a clonal proliferative disease. N Engl J Med. 1994;331:154-160.
9. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet. 1994;343:767-768.
10. Paulli M, Feller AC, Boveri E, et al. Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders. Virchows Arch. 1994;424:601-606.
11. Hage C, William CL, Favara BE, Isaacson PG. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction. Hum Pathol. 1993;24:840-845.
12. Eisen RN, Buckley PJ, Rosai J. Immunophenotypic characterization ofsinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Semin Diagn Pathol. 1990;7:74-82.
13. de Graaf JH, Tamminga RYJ, Kamps WA, Timens W. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation. Am J Pathol. 1994;144:466-472.
14. Quaglino P, Tomasini C, Novelli M, Colonna S, Bernengo MG. Immunohistologic findings and adhesion molecule pattern in primary pure cutaneous Rosai-Dorfman disease with xanthomatous features. Am J Dermatopathol. 1998;20:393-398.
15. Pardi R, Inverardi L, Bender JR. Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. Immunol Today. 1992;13:224-230.
16. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425-434.
17. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today. 1994;15:490-495.
18. McKenney JK, Weiss SW, Folpe AL. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol. 2001;25:1167-1173.
19. Ohto H, Maeda H, Shibata Y, et al. A novel leukocyte differentiation antigen: two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. Blood. 1985;66:873-881.
20. van Mourik JA, Leeksma OC, Reinders JH, de Groot PG, ZandbergenSpaargaren J. Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein Ila. J Biol Chem. 1985;260:11300-11306.
21. Goyert SM, Ferrero EM, Seremetis SV, Winchester RJ, Silver J, Mattison AC. Biochemistry and expression of myelomonocytic antigens. J Immunol. 1986;137:3909-3914.
22. Knapp W, Dorken B, Rieber P, Schmidt RE, Stein H, von dem Borne AEGK. CD antigens 1989. Blood. 1989;74:1448-1450.
23. Muller WA, Ratti CM, McDonnell SL, Cohn ZA. A human endothelial cell restricted externally disposed plasmalemmal protein enriched intercellular junctions. J Exp Med. 1989;170:399-414.
24. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 1990;247:1219-1222.
25. Stockinger H, Gadd SJ, Eher R, et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol. 1990;145:3889-3897.
26. Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK. Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets. Thromb Haemost. 1991;66:700-707.
27. Torimoto Y, Rothstein DM, Dang NH, Schlossman SF, Morimoto C. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J Immunol. 1992;148:388-396.
28. Ashman LK, Aylett GW. Expression of CD31 epitopes on human lymphocytes: CD31 monoclonal antibodies differentiate between naive (CD45 RA+) and memory (CD45 RA-) CD4-positive T cells. Tissue Antigens, 1991;38:208-212.
29. Emile J-F, Fraitag S, Leborgne M, de Prost Y, Brousse N. Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol. 1994;174:71-76.
30. Schmitz L, Favora BE. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:221-246.
31. Paulli M, Rosso R, Kindl S, et al. Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Hum Pathol. 1992;23:647-654.
32. Levine PH, Jahan N, Murari P, Manak M, Jaffe ES. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis. 1992;166:291-295.
33. Luppi M, Barozzi P, Garber R, et al. Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases. Am J Pathol. 1998;153:815-823.
34. Warnke RA, Weiss LM, Chan JKC, Cleary ML, Dorfman RF. Histiocytic and dendritic cell proliferations. In: Rosai J, ed. Tumors of the Lymph Nodes and Spleen. Washington, DC; Armed Forces Institute of Pathology; 1994:341-384.